Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Feb 2026 for Dynavax Technologies CORP. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Daniel l. Kisner: trading record in brief
This profile gathers the share dealings of Daniel l. Kisner across 2 companies, led by Dynavax Technologies Corp and Zynerba Pharmaceuticals, Inc. In total, 8 filings cover trades dated from 3 August 2021 to 10 February 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 10 February 2026: a transaction, in Dynavax Technologies Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel l. Kisner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,500 sharesCommon StockSEC:0001073407-26-000002:0
5,758 shares0Common StockSEC:0001029142-25-000104:0
5,357 shares0Common StockSEC:0000950170-24-065584:0
27,954 sharesCommon StockSEC:0001140361-23-047722:0
47,824 shares0Common StockSEC:0001062993-23-013666:0
5,357 shares0Common StockSEC:0001209191-23-033165:0
23,109 shares0Common StockSEC:0001062993-22-015042:0
5,000 shares0Common StockSEC:0001192482-21-000644:0
8 of 8 declarations
